Walgreens Boots Alliance, Inc. (WBA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

/EIN News/ -- NEW YORK, July 19, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Walgreens Boots Alliance, Inc. (“Walgreens Boots” or “the Company”) (NASDAQ: WBA). Investors who purchased Walgreens Boots securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/WBA.

Investigation Details

On June 27, 2024, Walgreens reported its earnings for the third quarter of 2024. According to The Motley Fool, “The big change was earnings guidance for the full year being cut from a range of $3.20 to $3.35 down to a range of $2.80 to $2.95 per share. This is the second time this year the company has cut guidance. Management said they would close some unprofitable stores and push back on some products it deems as too low a margin.” Following this news, Walgreens stock dropped over 22% that same day.

What's Next?

If you are aware of any facts relating to this investigation or purchased Walgreens Boots securities, you can assist this investigation by visiting the firm’s site: bgandg.com/WBA. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660.

There is No Cost to You

We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys’ fees, usually a percentage of the total recovery, only if we are successful.

Why Bronstein, Gewirtz & Grossman

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.

Attorney advertising. Prior results do not guarantee similar outcomes.

Contact

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Nathan Miller
332-239-2660 | info@bgandg.com